Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-10-08

Clinical Trial Update: Dose-response Relationship Study of S42909 on Leg Ulcer Healing [Phase 2]

View source ↗

Summary

Phase 2 dose-response study of S42909 for venous leg ulcers has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • S42909

Snippet

Sponsor: Ilkos Therapeutic Inc. | Conditions: Venous Leg Ulcer | Phase 2 | Status: COMPLETED | Results posted: 2020-10-08